Resumo

SALDARRIAGA, Clara; RENDON, Jairo A  e  SENIOR, Juan M. Heart failure associated to imatinib mesylate use: Case report. Rev. Col. Cardiol. [online]. 2008, vol.15, n.6, pp.297-299. ISSN 0120-5633.

Cardiotoxicity due to drugs has become a frequent event in the daily clinical practice. Fusion protein Brc/Abl inhibitors such as imatinib mesylate constitute a new tool for the treatment of some hematogical neoplasias, especially chronic myeloid leukemia. Nevertheless, there have been reports in the literature regarding imatinib mesylate toxicity. We present the case of a young woman with a structurally healthy heart who developed cardiotoxicity with imatinib few weeks after its initiation.

Palavras-chave : cardiotoxicty; imatinib mesylate; heart failure.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )